Related Experiment Videos
[Lambert-Eaton syndrome. Diagnostic, nosologic and therapeutic problems]
La Revue De Medecine Interne
|September 1, 1984
Summary
This study details Lambert-Eaton myasthenic syndrome, a disorder often linked to cancer. Diagnostic criteria involve specific electrodiagnostic responses, differentiating it from myasthenia gravis.
Area of Science:
- Neurology
- Clinical Electrophysiology
- Oncology
Background:
- Lambert-Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder affecting neuromuscular junctions.
- It is frequently paraneoplastic, often associated with small cell lung cancer.
- LEMS presents with distinct clinical features including proximal muscle weakness, autonomic dysfunction, and hyporeflexia.
Observation:
- Five cases of LEMS are presented, characterized by loss of deep tendon reflexes, dry mouth, and impotence.
- Diagnostic electrophysiological findings include a significant decrease in compound muscle action potential amplitude (>30%) at 5 Hz stimulation and a significant increase (>60%) at 30 Hz stimulation.
- This electrodiagnostic pattern is crucial for differentiating LEMS from myasthenia gravis.
Findings:
- The electrophysiological response profile is a key diagnostic marker for LEMS.
- LEMS is strongly associated with underlying malignancies, particularly bronchogenic carcinoma, even when seemingly isolated.
- The underlying pathophysiology involves a presynaptic blockade of neuromuscular transmission, likely due to a tumor-produced substance.
Implications:
- Early diagnosis and recognition of LEMS are critical for identifying occult malignancies.
- Understanding the presynaptic mechanism aids in targeted diagnostic and therapeutic strategies.
- Limited therapeutic options, such as Guanidine, highlight the need for further research into LEMS treatment.